MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab
- MorphoSys and Incyte to co-commercialize tafasitamab in the U.S. - Incyte has exclusive commercialization rights outside of the U.S....
Day: January 13, 2020
Great Bay Bio injected with 2.5 million USD of convertible note
HONG KONG, CHINA / ACCESSWIRE / January 12, 2020 / Recently, Great Bay Bio signed off convertible note, and the...
Flow Pharma, Inc. Presenting Mouse Breast Cancer Study Data
Flow Pharma CEO, Reid Rubsamen, M.D. will be presenting an update on the company's pre-clinical and clinical breast cancer studies...